Pharmacovigilance
Welcome to the Pharmacovigilance Department of Doctivo Lifesciences. Our commitment to patient safety and efficacy of our products is paramount. As a vital part of our mission, our Pharmacovigilance team diligently monitors, evaluates, and responds to any reports of adverse events associated with our products.
Information received from patients and healthcare providers via pharmacovigilance and medical literature, plays a critical role in providing the data necessary for pharmacovigilance. In fact, in order to market or to test a pharmaceutical product in most countries, adverse event data received by pharmaceutical company is required to be submitted to the local drug regulatory authority.
Thus, pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Companies must conduct a comprehensive drug safety and pharmacovigilance audit to assess their compliance with worldwide laws, regulations, and guidance
Our team of 10 EU/UK Qualified Persons for Pharmacovigilance (QPPV) and their deputies, as well as over
300 local contact persons responsible for PV (LCPPV) can help you set up and maintain complex global PV
systems and participate in non-routine PV activities. Their expertise
spans decades of industry experience, together with in-depth knowledge of industry trends and regulations.
-
- Monitor and Assess:
- Continuously monitor the safety profile of our products, ensuring they meet the highest standards of safety and efficacy.
-
- Compliance and Collaboration:
- Adhere to global regulatory requirements and collaborate with healthcare professionals, regulatory bodies, and patients to ensure transparent and effective communication.
-
- Education and Awareness:
- Provide healthcare professionals and patients with the necessary information to make informed choices about our products.
-
- Transparency and Responsiveness:
- We believe in open communication and prompt response to any safety concerns.
-
- Report and Analyze:
- Collect and analyze data on adverse events, making informed decisions to protect public health
-
- Innovation and Research:
- Engage in ongoing research to improve pharmacovigilance practices and methodologies, staying at the forefront of patient safety.Our Commitment:
-
- Patient-Centered Approach:
- Our priority is the well-being of patients who trust in our products. We are dedicated to ensuring their safety through rigorous monitoring and risk management.